153 related articles for article (PubMed ID: 1306317)
1. New strategies to establish human monoclonal antibodies.
Kudo T; Saeki H; Saijyo S; Sato N; Numasaki M; Tachibana T
Tohoku J Exp Med; 1992 Oct; 168(2):323-7. PubMed ID: 1306317
[TBL] [Abstract][Full Text] [Related]
2. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
3. Immunization of SCID-Hu mice and generation of anti-hepatitis B surface antigen-specific hybridomas by electrofusion.
Neil GA; Sammons DW
Hum Antibodies Hybridomas; 1992 Oct; 3(4):201-5. PubMed ID: 1477301
[TBL] [Abstract][Full Text] [Related]
4. Production of a human monoclonal antibody to a synthetic peptide by active in vivo immunization using a SCID mouse grafted with human lymphocytes.
Kudo T; Saijyo S; Saeki H; Sato N; Tachibana T; Habu S
Tohoku J Exp Med; 1993 Dec; 171(4):327-38. PubMed ID: 7514315
[TBL] [Abstract][Full Text] [Related]
5. In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas.
Wasserman RL; Budens RD; Thaxton ES
J Immunol Methods; 1986 Nov; 93(2):275-83. PubMed ID: 3534099
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to the chemotherapeutic agent methotrexate: production, properties and comparison with polyclonal antibodies.
Kato Y; Paterson A; Langone JJ
J Immunol Methods; 1984 Mar; 67(2):321-36. PubMed ID: 6707474
[TBL] [Abstract][Full Text] [Related]
7. Offspring of xenogeneically-reconstituted scid/scid mice are capable of a primary xenogeneic immune response to DNP-KLH.
Greenwood JD; Bos NA; Croy BA
Vet Immunol Immunopathol; 1996 Mar; 50(1-2):145-55. PubMed ID: 9157679
[TBL] [Abstract][Full Text] [Related]
8. Production of stable human-mouse hybridomas secreting monoclonal antibodies against Rh D and c antigens.
Rapaille A; François-Gérard C; Donnay D; Sondag-Thull D
Vox Sang; 1993; 64(3):161-6. PubMed ID: 8484248
[TBL] [Abstract][Full Text] [Related]
9. Analysis of human monoclonal antibodies derived from lymphocytes of patients with cancer.
Cote RJ; Morrissey DM; Oettgen HF; Old LJ
Fed Proc; 1984 Jun; 43(9):2465-9. PubMed ID: 6327400
[TBL] [Abstract][Full Text] [Related]
10. A new and efficient method to generate human IgG monoclonal antibodies reactive to cancer cells using SCID-hu mice.
Satoh N; Kudo T; Saeki H; Saijo S; Hasumi T; Yoshida H; Kobayashi S; Fujimura S
Immunol Lett; 1995; 47(1-2):113-9. PubMed ID: 8537087
[TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibodies from the hybridization of lymphocytes].
Ax W
Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991
[No Abstract] [Full Text] [Related]
12. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies: methods and clinical laboratory applications.
Nakamura RM
Clin Physiol Biochem; 1983; 1(2-5):160-72. PubMed ID: 6396016
[TBL] [Abstract][Full Text] [Related]
14. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
15. High efficiency creation of human monoclonal antibody-producing hybridomas.
Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
[TBL] [Abstract][Full Text] [Related]
16. [Monoclonal antibodies produced by human-human hybridomas].
Chida J
Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
[TBL] [Abstract][Full Text] [Related]
17. Development of specific human mab's by a small scale electrofusion technique: the influence of some physical and chemical factors on hybridoma yield of human peripheral blood lymphocytes XCB-F7 fusions.
Glaser RW; Jahn S; Grunow R
Allerg Immunol (Leipz); 1989; 35(2):123-32. PubMed ID: 2788981
[TBL] [Abstract][Full Text] [Related]
18. Production of stable heterohybridomas producing human monoclonal antibodies.
Cooper MD; Kirkpatrick R
Methods Mol Biol; 1995; 45():29-39. PubMed ID: 7550689
[No Abstract] [Full Text] [Related]
19. Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line.
Gigliotti F; Smith L; Insel RA
J Infect Dis; 1984 Jan; 149(1):43-7. PubMed ID: 6607295
[TBL] [Abstract][Full Text] [Related]
20. Selection of new heteromyeloma cell lines for the obtainment of human monoclonal antibodies.
Zanella I; Verardi R; Negrini R; Osio L; Albertini A; Ghielmi S
Year Immunol; 1993; 7():213-9. PubMed ID: 8396821
[No Abstract] [Full Text] [Related]
[Next] [New Search]
